Clincosm LogoSign in Get a demo

neurotrophic keratopathy

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurotrophic Keratopathy Trial (RGN-259, Placebo)

Not yet recruiting
  • Neurotrophic Keratopathy
  • (no location specified)
Sep 22, 2022

Neurotrophic Keratopathy Trial in United States (OC-01 (varenicline) nasal spray 1.2 mg/ml, Placebo (vehicle) nasal spray)

Recruiting
  • Neurotrophic Keratopathy
  • OC-01 (varenicline) nasal spray 1.2 mg/ml
  • Placebo (vehicle) nasal spray
  • Dothan, Alabama
  • +30 more
Aug 8, 2022

Neurotrophic Keratopathy Trial in Monterrey (PFAT first, APRP first)

Recruiting
  • Neurotrophic Keratopathy
  • PFAT first
  • APRP first
  • Monterrey, Nuevo Leon, Mexico
    Departamento de Oftalmologia, Hospital Universitario "Dr. Jose E
May 16, 2022

Neurotrophic Keratopathy Trial in Spain (Cord Blood Eye Drops, Conventional treatment)

Terminated
  • Neurotrophic Keratopathy
  • Cord Blood Eye Drops
  • Conventional treatment
  • Badalona, Barcelona, Spain
  • +9 more
Oct 23, 2020

Neurotrophic Keratopathy Trial in United States (RGN-259, Placebo)

Terminated
  • Neurotrophic Keratopathy
  • Lancaster, California
  • +10 more
Jun 30, 2020

Renewal of Corneal Nerves Structure and Function in Neurotrophic

Completed
  • Neurotrophic Keratopathy
  • Cenegermin, recombinant human Nerve Growth Factor (rhNGF) eyedrops
  • Chieti, Italy
    Ophtalmology Clinic, G.d'Annunzio University
Mar 3, 2020